Illumina
Trade Illumina 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ILMN
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions.
ILMN Key Statistics
Stock Snapshot
The current Illumina(ILMN) stock price is $141.47, with a market capitalization of 21.62B. The stock trades at a price-to-earnings (P/E) ratio of 32.61.
During the trading session on 2026-01-14, Illumina(ILMN) shares reached a daily high of $148.57 and a low of $141.35. At a current price of $141.47, the stock is +0.1% higher than the low and still -4.8% under the high.
Trading volume for Illumina(ILMN) stock has reached 608.62K, versus its average volume of 1.71M.
The stock's 52-week range extends from a low of $68.70 to a high of $153.06.
The stock's 52-week range extends from a low of $68.70 to a high of $153.06.
ILMN News
Illumina (ILMN) is back on investors’ screens after recent trading, with the share price closing at US$146.99. The move comes against a backdrop of mixed short...
In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Sell rating on Illumina, with a price target of $80.00. Claim 70% Of...
(RTTNews) - Illumina, Inc. (ILMN), a biotechnology company, on Tuesday reported preliminary results for the fourth quarter and fiscal 2025 above analysts' expec...
Analyst ratings
39%
of 23 ratingsMore ILMN News
Illumina (ILMN) introduced the world’s largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmace...
Illumina has recently appointed genomics veteran Eric D. Green, M.D., Ph.D., as Chief Medical Officer and launched its Illumina Connected Multiomics cloud platf...
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across biotech and industrial names on Friday, January 9, 2026. The firm incr...
Claim 70% Off TipRanks Premium An announcement from Illumina ( (ILMN) ) is now available. On January 8, 2026, Illumina announced that veteran genomics leader...
Eric Green, a former NIH director, is expected to become the chief medical officer of Illumina (ILMN), Jared Whitlock of Endpoints News reported. Claim 70% Off...